tradingkey.logo
tradingkey.logo
Suchen

IRadimed Corp

IRMD
Zur Watchlist hinzufügen
100.970USD
+2.930+2.99%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.29BMarktkapitalisierung
54.48KGV TTM

mehr Informationen über IRadimed Corp Unternehmen

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

IRadimed Corp Informationen

BörsenkürzelIRMD
Name des UnternehmensIRadimed Corp
IPO-datumJul 16, 2014
CEOSusi (Roger)
Anzahl der mitarbeiter160
WertpapierartOrdinary Share
GeschäftsjahresendeJul 16
Addresse12705 Ingenuity Drive
StadtORLANDO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32826
Telefon14076778022
Websitehttps://www.iradimed.com/
BörsenkürzelIRMD
IPO-datumJul 16, 2014
CEOSusi (Roger)

Führungskräfte von IRadimed Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von IRadimed Corp?

Die fünf größten Anteilseigner von IRadimed Corp sind: Mr. James B. (Jim) Hawkins

Wie viele Institutionen halten Anteile an IRadimed Corp (IRMD)?

Mit Stand vom 2026Q1 halten 407 Institutionen Anteile an IRadimed Corp, mit einem Gesamtmarktwert von etwa 8.32M, was 65.08% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -453182.00 gestiegen.

Was ist die größte Einnahmequelle von IRadimed Corp?

Am 2026Q1 erzielte das Geschäft mit MRI Compatible IV Infusion Pump Systems für IRadimed Corp den höchsten Umsatz in Höhe von 31.64M, was 37.75% des Gesamtumsatzes entspricht.